MTOR and cancer: miR-223 has been found to affect the cell cycle by regulating E2F1 35, migration and invasion in cancer cells by targeting EPB41L3 36, proliferation and tumor growth of cells by targeting IGF1R and downstream Akt/mTOR/p70S6K signaling pathway 37,38.